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CD40 ligand (CD154) takes part in regulation of the transition
to mononuclear cell dominance during peritonitis.
Background. CD40 is a member of the tumor necrosis fac-
tor (TNF) family of receptors whose ligand (CD154) is found
mainly on membranes of activated mononuclear cells. CD154-
CD40 cross-linking is a central event in antigen presentation,
B-cell activation, and regulation of cytokine and chemokine se-
cretion from various types of cells. We have previously demon-
strated in vitro the presence of CD40 on human peritoneal
mesothelial cells (PMC) and have also shown that CD40 lig-
ation synergizes with interferon-c (IFN-c) to up-regulate CC
chemokine secretion from these cells. The aim of the present
study was to investigate the role of CD40 ligation in leukocyte
recruitment during peritonitis.
Methods. Peritonitis was induced in mice by bacterial in-
oculation, CD40 levels were analyzed on PMC by reverse
transcription-polymerase chain reaction (RT-PCR) and im-
munohistochemistry. CD154 levels on leukocytes were analyzed
by flow cytometry and RT-PCR. Chemokines mRNA levels
were analyzed by RT-PCR. CD154 was blocked in vivo using
monoclonal antibodies.
Results. In mice inoculated by Staphylococcus epidermidis or
Escherichia coli, CD40 in PMC increased twofold at 24 hours
and CD154 was induced and reached a peak at 48 hours. In
both Gram-positive and Gram-negative-peritonitis, peritoneal
macrophages were the main peritoneal leukocyte population to
express CD154. Similar results were observed in human subjects
during peritonitis. Injection of CD154 blocking monoclonal an-
tibody (MR1) reduced the mononuclear infiltrate by 50% and
had no effect on granulocyte recruitment 48 hours after inocu-
lation of S. epidermidis.
Conclusion. Our data suggest that CD40 plays a signifi-
cant role in the process of the mononuclear infiltration during
peritonitis.
1These authors contributed equally to this work.
Key words: CD40, CD154, peritonitis, leukocyte recruitment,
chemokines.
Received for publication June 20, 2004
and in revised form August 19, 2004, and September 21, 2004
Accepted for publication October 14, 2004
C© 2005 by the International Society of Nephrology
CD40, a50 kD integral membrane protein belonging
to the tumor necrosis factor receptor (TNF-R) family, is
expressed on all antigen presenting cells as well as on
other cell types such as fibroblasts, epithelium, and en-
dothelial cells. The ligand of CD40 (CD154), a 39 kD
member of the TNF family, was initially detected on ac-
tivated T lymphocytes. Subsequent studies found func-
tional CD154 expression on other cell types such as
macrophages, dendritic cells, and mast cells [1–3]. CD40
ligation plays a major role in various immune processes
such as immunoglobulin isotype switching, antigen pre-
sentation, induction of cytokines, modulation of adhesion
molecule expression, and stimulation of chemokine se-
cretions [1–3]. The significance of CD40 is exemplified
by its key role in major pathologies, including graft rejec-
tion, autoimmunity, fibrosis, and artherosclerosis [4–7].
Peritonitis remains one of the major complications
of long-term continuous ambulatory peritoneal dialysis
(CAPD) treatment and is involved in deterioration of the
peritoneal membrane and mortality [8]. Staphylococcus
epidermidis, the most common pathogen of peritonitis in
CAPD patients, is responsible for 30% to 45% of this
complication.
Gram-negative bacteria cause 10% to 20% of infec-
tion, and contamination with more than one Gram-
negative organism (multiorganism infection) suggests
bowel perforation [9]. Recurrent episodes of inflamma-
tion damage the normal structure of the peritoneal mem-
brane and cause long-term complications such as scar-
ring and fibrosis, which prevent efficient diffusion across
the membrane and technique failure [10, 11]. Mesothe-
lial cells form a monolayer that covers the peritoneal
membrane. Their location between the peritoneal cav-
ity and peritoneal blood vessels gives them a key role
in intraperitoneal immune defense. Following stimula-
tion with inflammatory cytokines and bacterial prod-
ucts, mesothelial cells express human lymphocyte anti-
gen (HLA)-DR and intercellular adhesion molecules
(ICAM-1) molecules [12] and produce various cytokines
such as interleukin (IL)-6, IL-1a, and IL-1b [13, 14] as
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well as chemokines such as IL-8, monocyte chemoat-
tractant protein (MCP)-1 and regulated upon activation,
normal T-cell expressed and secreted (RANTES) [15–
18]. We recently demonstrated the expression of CD40
on primary culture of human peritoneal mesothelial
cells (PMCs) and found that CD40 ligation up-regulates
the production of IL-15, IL-8, RANTES, and MCP-1
[19, 20]. Interestingly, the secretion of the granulocytic
chemokine, IL-8, was suppressed when CD40 ligation
was performed in the presence of interferon-c (IFN-c).
In contrast, IFN-c exercised a strong synergetic effect
on CD40 ligation-induced secretion of RANTES and
MCP-1, both of which are CC chemokines that attract
mononuclear cells [19]. A similar effect of IFN-c has been
demonstrated by Robson et al [21]. We hypothesized,
therefore, that during the different phases of peritonitis,
CD40 plays an important role in the selective recruitment
of the leukocyte population by regulating chemokine se-
cretion. Although Yang et al [22] have shown that peri-
toneal macrophages of CAPD patients express CD154
during episodes of peritonitis, to the best of our knowl-
edge, the present study is the first to investigate in vivo the
expression of CD40 on PMCs. In order to shed light on the
role of CD40 during peritonitis, we tested the expression
of CD40 and CD154 in murine models of Gram-positive
and Gram-negative peritonitis as well as the effect of
CD154 blocking by monoclonal antibodies.
METHODS
Mice and bacterial strains
CD1 mice were bred and maintained in the animal lab-
oratory of the Soroka Medical Center. Experiments were
conducted with the permission of the Israel Committee
for Animal Experiments. We used female mice aged 10
to 12 weeks. S. epidermidis and Escherichia coli were cul-
tivated in LB broth (Conda Laboratories, Madrid, Spain)
and harvested during the log phase. Aliquots were stored
frozen in LB broth containing 30% glycerol.
Induction of peritonitis and cell isolation
from the peritoneal cavity
Peritonitis was induced in 9- to 12-week-old CD1 mice
by intraperitoneal injection of aliquots of S. epidermidis
(6 × 108 CFU) or E. coli (1.5 × 107 CFU). Pathogen
aliquots were kept at −70◦C in LB broth glycerol in or-
der to maintain the same injection doses in all the ex-
periments. The size of the inoculum was determined as
half the lethal dose for each pathogen. Peritoneal leuko-
cytes were harvested at indicated time points following in-
oculation by peritoneal lavage with phosphate-buffered
saline (PBS) containing 2% bovine serum albumin (BSA)
and 5 mmol/L ethylenediaminetetraacetic acid (EDTA).
Cells were then washed once, total leukocyte counts were
determined, and cells were incubated with monoclonal
antibodies in PBS containing 1% BSA and 0.05% sodium
azide.
Peritoneal imprinting for immunohistochemistry
and reverse transcription-polymerase chain
reaction (RT-PCR)
Peritonitis was induced by inoculation of S. epidermidis
as described above. At 24 hours, microscope slides (Su-
perfrost Plus, Menzel-Glaser, Germany) were applied to
the anterior liver surface by peeling off the mesothelial
monolayer. The slides were washed with PBS to remove
blood and nonadherent cells.
mRNA analysis
CD40, CD154, KC, and RANTES mRNA were deter-
mined by RT-PCR of total RNA extracted from mouse
PMC or peritoneal leukocytes. Mesothelial monolayers
imprinted on the slide or 106 leukocytes were lysed and
total RNA was extracted from the cells using the RNeasy
Mini Kit (Qiagen, Hilden, Germany). cDNA was pre-
pared as previously described [19]. For PCR we used the
following primers: b-actin sense GGG TCA GAA GGA
TTC CTA TG; b-actin antisense GGT CTC AAA CAT
GAT CTG GG; glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) sense CAA TGC ATC CTG CAC CAC
CAA; GAPDH antisense GTC ATT GAG AGC AAT
GCC AGC; CD40 sense ATT TGT GCC AGC CAG
GAA GCC G; CD40 antisense GCA TCC GGG ACT
TTA AAC CAC AGA; KC sense AAC GGA GAA AGA
AGA CAG ACT; KC antisense GAC GAG ACC AGG
AGA AAC AG; RANTES sense CAT CCT CAC TGC
AGC CGC C; and RANTES antisense CCA AGC TGG
CTA GGA CTA GAG. Regular PCR was performed and
analyzed on agarose gels as previously described [19].
Each experiment was amplified with at least two differ-
ent sets of cycles to assure that amplification was in the
exponential phase of PCR. We found that 30 to 35 cy-
cles for CD40 and 25 to 30 cycles for b-actin were in the
exponential phase of amplification, thus permitting com-
parison of mRNA levels in the different samples. Under
these conditions, we also found a linear dose-response
of the PCR product correlating to increasing doses of
cDNA.
Quantitative real-time PCR assays were carried out for
CD40, CD154, KC, and RANTES. Templates (7 lL) were
diluted fivefold, mixed with primers (0.2 mmol/L) and
Thermo-Start Master Mix (ABgene, Surrey, UK). SYBR
green I dye (Amresco, Cleveland, OH, USA) was added
to the reaction mixture. Reactions were conducted in the
Rotor-Gene real-time PCR machine (Corbett-Research,
Nortlake, Australia). Standard cycling conditions for this
instrument were used (15 minutes initial enzyme activa-
tion at 95◦C, then 40 cycles of 95◦C for 10 seconds, an-
nealing temperatures were set according to the primers
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for 15 seconds and elongation was performed at 72◦C for
20 seconds).
Immunohistochemistry
CD40 expression on mesothelial cells was detected
by immunohistochemistry. Mesothelial monolayer im-
prints taken as described above underwent fixation
with 70% ethanol for 30 minutes at 4◦C. Endoge-
nous peroxidase activity was blocked with 1% H2O2
for 10 minutes and then slides were rinsed in three
changes of PBS for 2 minutes each. We then incu-
bated the monolayer with a solution containing rat an-
timouse CD40 antibody (clone 3/23) (Serotec, Oxford,
UK) for 30 minutes at room temperature. Slides were
again rinsed with PBS and then incubated with biotin-SP-
conjugated AffiniPure Donkey Anti-Rat IgG (Jackson,
West Grove, PA, USA) for 30 minutes at room temper-
ature. Slides were rinsed once again and then incubated
with streptavidin-peroxidase solution using the ABC Kit
(Vector Laboratories, Burlingame, CA, USA) for 30 min-
utes at room temperature. After rinsing with PBS, slides
were covered with diaminobenzidine tetrahydrochloride
reagent mixture, 0.6% H2O2 reagent and substrate buffer
(Zymed, South San Francisco, CA, USA) for 7 minutes.
Slides were rinsed with distilled water and counterstain
was carried out for 2 additional minutes with the hema-
toxylin reagent (Zymed). The slides were rinsed once
more with water, incubated in PBS for 30 minutes, and
rinsed again with distilled water. Dehydration was per-
formed in a graded series of ethanol (from 50% to 100%),
and finally slide processing was completed with two drops
of Histomount (Zymed) and a cover slip. The intensity of
the brown precipitate staining was analyzed by image an-
alyzing software (Tina, version 2.10g, Raytes, Germany).
Analysis was performed on 50 cells in each slide. To define
background staining we used cells that were incubated
without the first antibody (anti-CD40).
Flow cytometry analysis
For flow cytometry analysis, peritoneal leukocytes were
harvested, rinsed with PBS and 1.5 × 106 cells were
stained in 100 lL PBS containing 1% BSA and 0.05%
sodium azide for 1 hour on ice with various combina-
tions of anti-CD154-polyethylene (PE) and fluorescein
isothiocyanate (FITC)-labeled leukocyte markers. Fol-
lowing staining, cells were washed and fixed in 0.2%
paraformaldehyde-PBS. Antibodies were diluted to rec-
ommended concentrations according to the manufac-
turer’s instructions. Nonspecific binding of antibodies was
adjusted with cells labeled with matching isotype con-
trol antibodies. In preliminary experiment nonspecific Fc
staining was excluded by the addition of Fc-blocking an-
tibodies (Rat Anti-Mouse CD32/16-UNLB) (Southern
Biotechnology Associates, Inc., Birmingham, AL, USA).
Addition of this antibody had no effect on CD154 staining
and on all other markers we have tested in this study.
At least 10,000 cells were analyzed per sample. Analy-
ses were conducted by a flow cytometer (FACS Calibur,
Becton Dickinson, Mountain View, CA, USA). Fluores-
cence data were analyzed by the Cell Quest program and
presented in the form of two-parameter probability plots.
Antibodies
The following monoclonal antibodies were used: R-
PE-conjugated hamster antimouse CD154 monoclonal
antibody (clone 39H5) (Serotec); FITC-conjugated rat
antimouse F4/80 monoclonal antibody (clone CI:A3-1)
(Serotec); FITC-conjugated rat antimouse Ly-6G (GR-
1) monoclonal antibody (clone RB6-8C5) (Pharmin-
gen, San Diego, CA, USA); biotin-conjugated hamster
antimouse CD3e monoclonal antibody (clone 500A2)
(Pharmingen); R-PE-conjugated streptavidin (Jackson);
R-PE-conjugated mouse antihuman CD154 monoclonal
antibody (clone TRAP1) (Dako, Glostrup, Denmark);
FITC-conjugated mouse antihuman CD14 monoclonal
antibody (clone TUK4) (Dako); FITC-conjugated mouse
antihuman CD4 monoclonal antibody (clone MT310)
(Dako); and R-PE-conjugated mouse antihuman CD8
monoclonal antibody (clone DK25) (Dako). Hamster an-
timouse CD154 monoclonal antibody (MR1) was purified
from culture supernatant of hybridoma by affinity chro-
matography (anti-Armenian hamster IgG). Polyclonal
hamster IgG was purchased from Jackson. Fc-blocking
antibody (Rat Anti-MouseCD32/16-UNLB) Southern
Biotechnology Associates, Inc.).
Human peritonitis
Experiments were approved by the Helsinki Commit-
tee of the Ben Gurion University of the Negev Center for
Health Sciences.
We analyzed leukocytes from peritoneal effluents of
two CAPD patients (patient 1 and patient 2) suffering
from peritonitis. These patients were randomly selected,
and found to be infected by Gram-negative bacteria; pa-
tient 1 was infected with Serratia marcescens and patient
2 with Pseudomonas aeruginosa.
Blocking CD154 in vivo
Five hours before inoculation of S. epidermidis, mice
were injected intraperitoneally with 100 lg of anti-CD154
(MR1) monoclonal antibodies or with control polyclonal
hamster IgG. At 48 hours, peritoneal cells were harvested
and analyzed for leukocyte markers as described above.
Statistics
Results are expressed as mean ± SE. To compare lev-
els between groups we used unpaired two-tailed Student
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Fig. 1. Leukocyte counts and profiles during peritonitis. Peritonitis was induced in CD1 mice by intraperitoneal injection of aliquots of Escherichia
coli (A) or Staphlococcus epidermidis (C). Peritoneal lavage was performed at the indicated time points after inoculation, and leukocyte counts
were determined (A and C, upper panels). Peritoneal leukocytes were labeled with fluorescent monoclonal antibodies for peritoneal macrophages
(F4/80), granulocytes (GR1), and lymphocytes (CD3e, a T-cell marker, and B220, a B-cell marker), and flow cytometry analysis was performed. The
major leukocyte populations were identified by forward and side scatter (FSC-SSC) plot gating in combination with the specific cell markers. The
percentage of each specific cell population from the total population at each indicated time point (A and C, lower panels). (B) A representative
flow cytometry dot plot of FSC-SSC leukocytes of cells obtained from peritoneal lavage at 48 hours from inoculation with S. epidermidis. Results
are presented as mean ± SE (N = 3-5 for each time point). Abbreviations are: GR, granulocytes; M, macrophages; and L, lymphocytes.
t test or analysis of variance (ANOVA) with Tukey’s mul-
tiple comparison tests. Correlation was tested by Pear-
son correlation test. P values below 0.05 were considered
significant.
RESULTS
Leukocyte counts and profiles in a mouse
model of peritonitis
For induction of peritonitis, we used two bacterial mod-
els that represent the most common kinds of pathogens in
peritonitis of CAPD patients, S. epidermidis and E. coli.
As shown in Figure 1 (A and C, upper panels), in both
models total cell counts increased following bacterial in-
oculation, peaked at 12 hours (1.6 × 106 to 30 × 106 cells),
and then gradually decreased. Flow cytometry was used
to analyze leukocyte populations. As shown in Figure 1B,
the main leukocyte populations during peritonitis could
be recognized by their typical forward and side scatter
(FSC-SSC) profile. However, for precise analysis, in ad-
dition to the FSC-SSC profile, we used specific leuko-
cyte markers (B220 and CD3e for lymphocytes, F4/80 for
peritoneal macrophages, and GR1 for granulocytes). As
shown in Figure 1A and C, lower panels, the peritoni-
tis models presented a typical leukocyte profile, charac-
terized by a shift from granulocytic infiltrate during the
initial hours of peritonitis to a mononuclear infiltrate at
later stages. In both mouse models, granulocytic infiltrate
(GR1-positive cells) peaked at 12 hours. In the E. coli
model granulocytes reached approximately 75% of to-
tal leukocytes (22 × 106 cells) and in the S. epidermidis
model ∼50% (16 × 106 cells). The mononuclear infiltrate
(peritoneal macrophages and lymphocytes) in the S. epi-
dermidis model peaked at 24 hours (14 × 106 cells), while
in the E. coli model it peaked at 72 hours (11 × 106 cells).
The delayed shift to dominance of mononuclear cells in
the E. coli model compared to the S. epidermidis model
can be attributed to the stronger magnitude of inflam-
matory response in the Gram-negative peritonitis model
[23, 24].
CD40 levels on PMC during peritonitis
To demonstrate CD40 expression in vivo, mesothelial
monolayers covering the liver were imprinted on micro-
scope slides following inoculation, and analyzed for CD40
mRNA levels by RT-PCR (Fig. 2A and B) and for CD40
protein levels (Fig. 2C) by immunohistochemistry. Using
both standard RT-PCR and gel analysis (Fig. 2A, upper
panel) and by quantitative real time PCR (Fig. 2A, lower
panel) we found basal mRNA levels of CD40 in quies-
cent mesothelial cells which increased twofold at 24 hours
following S. epidermidis inoculation.
Similar results increased levels compared to basal lev-
els of brown cytoplasmatic deposits that represent CD40
protein (Fig. 2C).
As shown Figure 2B, detailed kinetics analyzed by real-
time PCR revealed that CD40 mRNA levels increase
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Fig. 2. CD40 levels in peritoneal mesothelial cells (PMC) during peritonitis. (A) Peritonitis was induced in mice by inoculation of Staphylococcus
epidermidis. At 24 hours, mesothelial monolayers covering the liver were imprinted on microscope slides. Total RNA was extracted from the cells
and reverse transcription-polymerase chain reaction (RT-PCR) was performed to amplify CD40 and b-actin cDNAs. Each lane represents one
animal. The samples were run on 1.5% agarose gel containing ethidium bromide (upper panel). Real-time PCR analysis of the same samples is
represented as the CD40/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ratio (lower panel). Results are presented as mean ± SE (N =
3 for each group). ∗P < 0.05. (B) Mice were inoculated by Escherichia coli, total RNA was extracted from imprints at indicated time points and
analyzed by real-time PCR. Results are presented as mean ± SE (N = 5 for each group). ∗P < 0.05. (C) CD40 expression in peritoneal mesothelial
cells (PMCs)-imprinted slides was detected by immunohistochemistry using a specific monoclonal antibody (upper panel). In control slides for
background staining, the first antibody (Ab) (aCD40) was omitted. The staining optical density (OD) (the cytoplasmatic brown deposit) was
quantified by image analysis software (lower panel). Results are presented as mean ± SE (N = 3 for each group). ∗P < 0.05.
following E. coli inoculation, peak at 6 hour to levels 15
times higher than basal levels, then decrease and stabilize
at levels two- to fivefold higher than basal levels at 24 to
72 hours.
CD154 expression during peritonitis
We analyzed CD154 expression on the peritoneal
leukocyte infiltrate by flow cytometry (Fig. 3). For this
purpose, double-staining of CD154 and markers of the
major leukocyte populations was performed. As depicted
in Figure 3A to D, resting peritoneal cells (0 hours) were
CD154-negative. However, following inoculation with ei-
ther S. epidermidis or E. coli, there was a gradual increase
in CD154-positive cells on peritoneal macrophage cells
(F4/80-positive cells) with peak expression of CD154 on
peritoneal macrophage at 48 hours when approximately
50% of the cells were CD154-positive (Fig. 3B and C).
In the E. coli model (Fig. 3B), 15% to 20% of the peri-
toneal lymphocytes were positive for CD154 at 12 and
24 hours following inoculation. In contrast, CD154 could
not be detected on lymphocytes following S. epidermidis
inoculation. This differential activation of lymphocytes
may be due to the heightened inflammatory response in
the Gram-negative peritonitis.
Peritoneal granulocytes (GR1-positive cells) were
CD154-negative in both mouse models at all indicated
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Fig. 3. CD154 expression on peritoneal leukocytes during peritonitis. (A) Representative flow cytometry dot plot of peritoneal leukocytes double-
stained for F4/80 and CD154 at the indicated time points following Escherichia coli inoculation. Peritoneal infiltrates were collected at indicated
time points following inoculation of E. coli (B) or Staphylococcus epidermidis (C). The peritoneal leukocytes were double-stained for CD154 and for
specific cell markers, and flow cytometry analysis was performed. Results are presented as mean ± SE of% CD154-positive cells (N = 3-5 for each
time point). (D) A plot of calculated total leukocyte numbers positive for CD154 obtained from mean total leukocytes counts and mean percentage
of CD154-positive cells at each time point after inoculation. Results are presented as mean CD154-positive cell-number (N = 3-5 for each time
point). (E) Real-time polymerase chain reaction (PCR) analysis of CD154 mRNA levels in peritoneal leukocytes following inoculation of E. coli
or control is represented as the CD154/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ratio (N = 3 for each time point). Abbreviations
are: GR, granulocytes; PM, peritoneal macrophages; Lymp, lymphocytes; CT, control.
time points. Figure 3D depicts the calculated total CD154-
positive cells. CD154-positive cell numbers increased
over time and reached plateau levels at ∼48 hours. In-
terestingly, we observed a small peak at 12 hours which
decreased at 24 hours in E. coli and remain unchanged
in mice inoculated with S. epidermidis. In mice inocu-
lated with S. epidermidis CD154-positive cells at 48 hours
were double that of E. coli–inoculated mice. The increase
of mononuclear infiltrate ratio (Fig. 1A and C, lower
panels) was in positive correlation with the number of
CD154-positive cells (r = 0.85 for S. epidermidis and 0.72
for E. coli) (Fig. 3D). Strong correlation (r = 0.89) was
also found between the number of CD154-positive cells
(Fig. 3D) and the absolute number of mononuclear cells
following E. coli inoculation (Fig. 1A, upper panel). How-
ever, the number of mononuclear cells following S. epider-
midis inoculation peaked at 24 hours and then declined
(Fig. 1C, upper panel) in contrast to the gradual increase
in CD154-positive cells up to 72 hours (Fig. 3D).
The quantitative profile of CD154 mRNA levels
in peritoneal leukocytes following E. coli inoculation
(Fig. 3E) is comparable to the E. coli total CD154 pro-
file (Fig. 3D): an early peak at 6 hours, reduced levels at
24 hours, and an increase of CD154 mRNA levels up to
72 hours.
Chemokine induction during peritonitis
We followed the mRNA levels of KC, the mice
analogue of IL-8, a chemoattractant of granulocytes
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Fig. 4. KC and regulated upon activation, normal T-cell expressed
and secreted (RANTES) mRNA levels in peritoneal mesothelial cells
(PMCs) during peritonitis. Peritonitis was induced in mice by inocula-
tion of Escherichia coli. Mesothelial monolayers covering the liver were
imprinted on microscope slides at the indicated time points, total RNA
was extracted from the cells and analyzed by real-time polymerase chain
reaction (PCR) for KC (A) and RANTES (B). The insert illustrates ki-
netics with a more detailed time scale for the first hours of peritonitis.
Results are presented as mean ± SE (N = 3 for each time point). Ab-
breviations are: GADPH, glyceraldehyde-3-phosphate dehydrogenase;
CT, control.
(Fig. 4A), and RANTES, a chemoattractant of mononu-
clear cells (Fig. 4B). Following E. coli inoculation, KC
mRNA levels peaked at 3 hours and declined to basal lev-
els at 12 hours. RANTES mRNA showed an early peak
at 6 hours which reduced at 24 hours and gradually in-
creased up to 72 hours.
CD154 expression during peritonitis in human subjects
In order to corroborate the results obtained from the
mouse models in human patients with peritonitis, peri-
toneal leukocytes were collected from two CAPD pa-
tients at 48 and 72 hours after peritonitis manifestation.
As depicted in Figure 5, similar to the animal mod-
els, CD154 expression was detected mainly on human
peritoneal macrophages(CD14-positive cells). More than
70% of the peritoneal macrophages in patient 1 and
∼30% of the peritoneal macrophages? in patient 2 were
positive for CD154 at 72 hours. CD154 expression was
also detected in ∼10% of the T cells (CD3-positive cells)
of patient 1 and in 2% of the T cells of patient 2 at 72 hours.
CD154 blocking in vivo
To test the role of CD154 in regulation of leukocyte
recruitment we injected blocking monoclonal antibodies
(MR1) to mice inoculated with S. epidermidis. We tested
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Fig. 5. CD154 expression on human peritoneal leukocytes during peri-
tonitis. Human peritoneal leukocytes were collected from dialysis ef-
fluents of two continuous ambulatory peritoneal dialysis (CAPD)-
treated patients during peritonitis episodes. The peritoneal leukocytes
were double-stained for CD154 and for the specific cell markers for
macrophages (CD14) and lymphocytes (CD4 and CD8) and flow cy-
tometry analysis was performed. Results are presented as% CD154-
positive cells at indicated time points following peritonitis propagation.
Abbreviations are: GR, granulocytes; M, macrophages; and Lymph,
lymphocytes.
the effects of this treatment at 48 hours from inoculation
since in preliminary experiments, at this time point, gran-
ulocyte and mononuclear cells populations were almost
equal in size, and probably changes in their ratio follow-
ing treatment would be more pronounced. As depicted
in Figure 6A, compared to the control, total cell recruit-
ment at 48 hours was reduced by 35% (P < 0.01). Flow
cytometry analysis, revealed a substantial shift in leuko-
cyte ratio forward granulocytes in the aCD154-treated
animals (Fig. 6B). Calculation of cell numbers revealed
a ∼50% reduction in B cells, T cells (P < 0.001) and in
peritoneal macrophages (P < 0.05) as compared to the
control while no significant changes could be detected in
the number of granulocytes (Fig. 6C).
DISCUSSION
This study demonstrates the expression of CD40 on
PMC and the kinetics of expression of its ligand CD154
on leukocytes during peritonitis. We used S. epidermidis
and E. coli models of mice peritonitis in order to best
reflect the pathogens that frequently cause human peri-
tonitis [9]. The mouse models demonstrated a normal pat-
tern of bacterial peritonitis characterized by a rise in total
leukocyte cell count and an initial massive granulocyte in-
filtrate followed by recruitment of mononuclear cells. The
Gram-negative (E. coli) model presented the strongest
magnitude of inflammatory response with a longer course
of inflammation and delayed shift to mononuclear cells,
which is comparable to the usual course of human peri-
tonitis [23, 24].
In previous studies, we have demonstrated the pres-
ence of CD40 on isolated human PMC as well as an
impressive synergism between inflammatory cytokines
and CD40 ligation for the induction of chemokines [19,
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Fig. 6. The effect of CD154 blocking on
leukocyte counts and profiles during peritoni-
tis. Mice were treated with aCD154 mono-
clonal antibody (100lg) or control hamster
IgG antibody (CT). At 6 hours peritonitis
was induced in mice by Staphylococcus epi-
dermidis inoculation. Peritoneal lavage was
performed at 48 hours after inoculation. (A)
Total leukocyte counts. (B) Representative
flow cytometry scatter and side dot plot of
forward and side scatter (FSC-SSC) of peri-
toneal leukocytes. (C) Calculated leukocyte
population counts from total counts and flow
cytometry analysis of leukocyte populations.
Results are presented as mean ± SE (N = 5
for each group). ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P <
0.001. Abbreviations are: GR, granulocytes;
M, macrophages.
20]. The present study demonstrates in vivo the presence
of CD40 mRNA and protein during mouse peritonitis.
Similar to our previous finding on cytokine-stimulated
human PMC [19], in the current study we found an in-
crease of CD40 levels during peritonitis. The mRNA lev-
els of CD40 peak shortly after inoculation and remain
elevated during peritonitis. The observation that PMC
express CD40 is consistent with recent reports describ-
ing CD40 expression on various hematopoietic and non-
hematopoietic cell types such as macrophages, fibroblasts,
endothelial, and epithelial cells [1, 2]. In support of our
results, other studies have reported the up-regulation of
CD40 levels under various pathologic conditions such as
rheumatoid arthritis, neurologic disorders, graft-versus-
host disease, or atherosclerosis [2, 3].
Our data indicate that CD154 expression is induced
during peritonitis. We found that for both Gram-positive
and Gram-negative-peritonitis, peritoneal macrophages
are the main leukocyte population to express CD154. In
contrast to constitutive expression of CD40 on PMC, we
did not find any basal expression of CD154 on resting
peritoneal leukocytes. Our results show that CD154 ex-
pression gradually increases starting several hours after
inoculation and peaks at 48 hours. These findings in ani-
mal models correlate with our results in human peritoni-
tis. We also found an early peak of CD154 at 6 to 12 hours
which was more pronounced in the E. coli model and was
observed by mRNA analysis and by flow cytometry. The
flow cytometry data suggest that this early peak is the
outcome of a short CD154 induction on lymphocytes and
the major increase that follows is the outcome of CD154
induction on macrophages.
Although CD154 was initially considered to be a
marker of activated T cells, our results as well as other
studies have demonstrated that different cell types such
as monocytes/macrophages, mast cells, endothelial, and
smooth muscle cells show inducible expression of CD154
[3]. In the models of peritonitis, we have presently de-
scribed, only a small fraction of lymphocytes were posi-
tive for CD154 and only in peritonitis induced by E. coli.
The differential expression of CD154 on lymphocytes
in the two models could be explained by the stronger
extent of inflammatory response to Gram-negative bac-
teria compared to S. epidermidis. The data we provide
regarding CD154 expression on two human subjects are
validated by a previous finding of Yang et al [22] which
demonstrated that during peritonitis CD154 is induced
on human peritoneal macrophages. The relevance of our
data on mice and human subjects in the present study are
further validated by our findings in a later study on 11
peritoneal dialysis treated patients in which we show a
positive correlation between CD154 levels on leukocytes
and mononuclear dominance in the peritoneum (submit-
ted for publication). This correlation supports our hy-
pothesis that high CD154 levels increase mononuclear
recruitment. Our data also show that CD40 signaling
plays a major regulatory role in cell recruitment to the
peritoneum. Following bacterial contamination during
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the first phase of inflammation, most infiltrating cells are
granulocytes, which do not express CD154. At this in-
flammatory stage, the main signals that activate PMC are
probably proinflammatory cytokines such as IL-1 and
TNF-a secreted from resident peritoneal macrophages.
These cytokines induce PMC to mainly secrete chemoat-
tractants of granulocytes, such as IL-8 which precipitates
the recruitment of neutrophils [25–27]. Indeed our data
demonstrate that the mRNA of KC, the mouse ana-
logue of IL-8, is strongly induced in PMC at first hours
of inflammation. Furthermore, we show that the next
phase of inflammation is characterized by accumulation
of mononuclear cells that express CD154 and that block-
ing of CD154 significantly reduces this cell population. It
is likely that during this second phase, T cells become ac-
tivated and secrete INF-c. Man et al [20] and Robson et al
[21] as well as one of our recent studies demonstrated that
INF-c inhibits the secretion of IL-8 from PMC. In con-
trast to the effect on IL-8, we previously found that CD40
activation is highly synergic to INF-c for up-regulation of
the mononuclear CC chemokines, MCP-1 and RANTES
[19, 20]. Our present work shows that RANTES mRNA
levels at the late phase of inflammation correlate with
CD154 levels. The considerable early peak of RANTES
mRNA at 6 hours of inflammation could be due to the
synergistic induction by TNF and IL-1, as we have pre-
viously demonstrated [20]. This chemokine “switching”
mediated by CD40 and IFN-c could explain the change
from granulocytic infiltrate during the first hours of in-
flammation to dominance of mononuclear cells in the
late phase of peritonitis. Thus, the reduced mononuclear
population we observed following blocking of CD154 is
most probably the result of a weakened chemokine sig-
nal produced by PMC when CD40 is not activated. The
CD154-positive cell count correlated with the number of
mononuclear cells after E. coli inoculation. However, fol-
lowing inoculation with S. epidermidis, there was a match
between CD154 levels and the initial increase of mononu-
clear cells (0 to 24 hours) but no correlation was observed
with the decrease of mononuclear cell number in the res-
olution phase of peritonitis (48 to 72 hours). In this last
phase, CD154 cells continued to increase while mononu-
clear cell numbers declined. This discrepancy between
CD154 levels and mononuclear infiltrate could be ex-
plained by the low levels of inflammatory cytokines which
are characteristic of the resolution phase of peritonitis.
Since proinflammatory cytokines synergize with CD40
ligation to induce significant levels of CC chemokines
[19, 20], even high CD154 levels in the presence of low
IL-1, TNF-a, or IFN-c will not effectively induce the re-
cruitment of mononuclear cells.
The reduced mononuclear infiltration we observed fol-
lowing injection of anti-CD154 may also be explained by
Fc-mediated depletion of CD154+ cells, as described in
a recent study by Monk et al [28]. However, while this
mechanism may be a possible explanation for the deple-
tion of CD154 effector cells it does not account for the
massive reduction of mononuclear cells, since the reduc-
tion of B cells, which do not express CD154, was similar
to T cells and peritoneal macrophages which may tran-
siently express CD154.
Hurst et al [18] have recently suggested that IL-6 se-
creted from PMC and its soluble receptor (sIL-6) released
from granulocytes also play a central role in suppressing
CXC chemokine expression and promoting MCP-1. It
is likely that both suggested mechanisms for chemokine
“switching” play a parallel or sequential role in the reg-
ulation of leukocyte recruitment. It should also be noted
that CD40 ligation has been shown to up-regulate IL-
6 secretion from endothelial cells [29]. CD40, therefore,
might mediate chemokine “switching” directly or indi-
rectly through the up-regulation of IL-6 secretion.
We focused our study on regulation of chemokine se-
cretion from PMC since due to their location they serve
as “gatekeeper” between the peritoneal cavity and peri-
toneal blood vessels. Nevertheless, it should be borne in
mind that during peritonitis CD154-positive cells stimu-
late also other cell types that express CD40-like B cells,
peritoneal macrophages and endothelial cells and that
these interactions have an important regulatory role in
cell recruitment and development of a specific immune
response.
In addition to its involvement in acute inflammatory re-
sponses, CD40-CD154 interaction has been shown to play
a major role in various chronic pathologies, such as lupus
nephritis, lung fibrosis, multiple sclerosis, and atheroscle-
rosis. Anti-CD154 treatment has been suggested as a ther-
apy for these diseases [5–7, 30, 31]. Peritoneal fibrosis has
also been reported to increased morbidity and mortality
in peritoneal dialysis patients and thus is a major cause
for discontinuance of CAPD treatment [10, 11]. In light
of CD40 involvement in chronic diseases, further inves-
tigation is required to examine whether blockade of the
CD40-CD154 pathway can suppress fibrotic processes in
the peritoneum.
CONCLUSION
Our data indicate that CD40 is present on PMC and up-
regulated during peritonitis, its ligand CD154 is induced
on mononuclear cells, and that CD40 signaling plays a
major role in mononuclear cell recruitment during peri-
tonitis.
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